TrialAnnals of the rheumatic diseases2023

Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance.

Lars Erik Kristensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.